Maltese Scientists Work on Wits

Courtesy of Malta Tourism AuthorityRichard Muscat rarely tunes in to the daily news, but while tending to his children last November, he overheard a TV newscast that stopped him. The prime minister had set aside €800,000 to launch a national research program. For the first time ever, the government allocated money to research. "Thank heavens," Muscat recalls thinking. "They have finally done it."Muscat, a neuroscientist at the University of Malta, and his colleagues had lobbied the Maltese

Written byMartina Habeck
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Courtesy of Malta Tourism Authority

Richard Muscat rarely tunes in to the daily news, but while tending to his children last November, he overheard a TV newscast that stopped him. The prime minister had set aside €800,000 to launch a national research program. For the first time ever, the government allocated money to research. "Thank heavens," Muscat recalls thinking. "They have finally done it."

Muscat, a neuroscientist at the University of Malta, and his colleagues had lobbied the Maltese government since the mid-90s to put research on the national agenda. It had not been an easy task: The Maltese islands, located in the center of the Mediterranean Sea and together hardly half the size of London, make their main income from the sun and the sea: The million tourists per year outnumber the islands' population by a factor of 2.5. Research is still considered an unnecessary extra, funded through the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies